跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BI-1
首页
药物
BI-1
BI-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Bi-pyridinyl derivatives as NK-1 antagonists
申请人: HOFFMANN TORSTEN
优先权: 2005
US
2 件公开
Bi-inulicin 1, preparation method and applications thereof
申请人: UNIV PLA 2ND MILITARY MEDICAL
优先权: 2008
CN
大豆BI-1基因及应用
申请人: 信阳师范学院
优先权: 2018
CN
Bi-functional shRNA targeting Stathmin 1 and uses thereof
申请人: RAO DONALD
优先权: 2012
US
2 件公开
BI-SPECIFIC BINDING AGENTS TARGETING SYNDECAN-1 AND FIBROBLAST GROWTH FACTOR RECEPTOR
申请人: MITSUBISHI TANABE PHARMA CORP
优先权: 2018
CN
1, 4-dimethyl-2, 5-bi-1H-1, 2, 4-bis (triazol 1 yl) two-dimensional copper complex single crystal and application
申请人: UNIV TIANJIN
优先权: 2016
CN
Bi-specific antibodies against TIM-3 and PD-1 for immunotherapy in chronic immune conditions
申请人: KUCHROO VIJAY K
优先权: 2011
US
5 件公开
COMBINATION THERAPIES WITH BI-SPECIFIC ANTI-EGFR/C-MET ANTIBODIES AND ANTI-PD-1 ANTIBODIES
申请人: JANSSEN BIOTECH INC
优先权: 2023
EP
WO
2 件公开
药物
反馈